BioMedHeparin Anti-Xa肝素(抗因子Xa)221003点击次数:1199发布时间:2014/7/21价格:￥1500 更新日期:2024/8/5 18:39:26 生产地:中国大陆 产品型号: 简单介绍:BioMed 常用的发色底物 法国HYPHEN BioMed公司(简称HBM)--欧洲知名血液产品生产商,通过ISO9001和ISO13485双项认证,生产的大部分产品均通过欧洲CE认证,为...
Anti-Xa (2 Stages Heparin Assay) 货号: 221005 是否进口: 是 产品名称:BIOPHEN™ Anti-Xa(2 阶段肝素检测) 英文名称:BIOPHEN™ Anti-Xa (2 Stages Heparin Assay) 品牌:Hyphen-BioMed 产品描述:根据药典,用于在血浆或纯化培养基上测量肝素活性的两阶段抗 Xa 显色法。 该测定法使用抗凝血酶和 Xa ...
234: HIGH- VERSUS LOW-RANGE ANTI-XA GOALS FOR IV HEPARIN IN PATIENTS WITH MECHANICAL CIRCULATORY SUPPORTdoi:10.1097/01.ccm.0001099600.71128.22Wang, YueTo, LongJones, MathewBasir, MirGrafton, GillianVillalba, PaulGriebe, KristinLippincott Williams & WilkinsCritical Care Medicine...
英文名称: Anti-Xa(LMH anti-Xa)ELISA kit for porcine low molecular weight heparin 用途: 科研试验 产地: 上海 品牌: 佰利莱生物 包装规格: 96T/48T 标记物: HRP标记物 样本: 血清,血浆,唾液,尿液,组织,细胞上清,裂解液等 检测方法: 酶联免疫法 应用: 定性检测/定量检测/酶活检测 检测限:...
anti-Xa 0.2-0.7 0.29(0.18-0.37) 0.36(0.25-0.46) Weak: r = 0.190 (p = 0.064) Yes: Mean anti-Xa significantly lower in patients with thromboembolic events Deshpande et al. anti-Xa 0.3-0.7 - - Weak No: No significant association between anti-Xa level, aPTT, ACT, or heparin dose and ...
Changing a heparin order set to utilize anti Xa monitoring and to improve time to therapeutic anticoagulationMoyers, PTatro, JFerguson, TBall, JTimmons, C
211: EVALUATION OF ANTI-XA AND APTT MONITORING OF HEPARIN IN ADULT PATIENTS RECEIVING ECMO SUPPORTdoi:10.1097/01.ccm.0000528230.71573.b0Arnouk, SerenaAltshuler, DianaMerchan, CristianZakhary, BishoyPapadopoulos, JohnCRITICAL CARE MEDICINE -BALTIMORE-...
The anti- Xa-activity of the heparin applicated by jet injection was significantly higher (maximal effect after 3 hrs: 0.24 vs 0.20 USP heparin/ml plasma, p < 0.01, area under the time related curve p < 0.01). The data indicate, that the bioavailability of heparin for factor Xa is even...
In the derivation cohort, heparin anti-Xa activity ≤0.2, ≤0.3, <0.1, <0.1 IU·mL reliably ruled out a relevant level of apixaban, rivaroxaban, fondaparinux, and danaparoid, respectively (area under the ROC curve ≥0.99). In the validation cohort, these cutoffs yielded excellent ...
Instead, anti-Xa monitoring of low molecular weight heparin is recommended for patients with renal dysfunction, severe obesity or patients at high risk for thrombosis/bleeding. In our department, we followed a protocol of an individualized prophylactic anticoagulation based on anti-Xa measurement. Speci...